P. Ney, R. Pandita, D. Newgreen
Apr 1, 2008
Citations
6
Influential Citations
64
Citations
Quality indicators
Journal
BJU International
Abstract
To investigate the primary pharmacology of fesoterodine (a novel antimuscarinic drug developed for treating overactive bladder) and SPM 7605 (its active metabolite, considered to be the main pharmacologically active principle of fesoterodine in man) against human muscarinic receptor subtypes, and to investigate in vitro and in vivo functional activity of these agents on the rat bladder compared with existing standard agents.